CureMatch’s Tsigelny is a featured author in Briefings in Bioinformatics journal with a review on artificial intelligence’s usefulness in drug combination therapy recommendations. SAN DIEGO, CA – February 12, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Science Officer at CureMatch®, is the author of “Artificial intelligence in drug combination therapy” in Briefings in Bioinformatics […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.